Top

Published in:

01-08-2011 | Editorial

Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents

Authors: Guy Sisson, Ingvar Bjarnason

Published in: Inflammopharmacology | Issue 4/2011

Excerpt

The use of non-steroidal anti-inflammatory drugs (NSAIDs) is steadily increasing. The main concerns with this class of drugs are the frequency and severity of their gastrointestinal side effects (Hayllar et al. 1992). This is particularly so now that the focus on their adverse cardiovascular effects, especially with the cyclo-oxygenase (COX)-2 selective agents, seems to be waning. …

Arora G, Singh G, Vadhavkar S, Shah SB, Mannalithara A, Mithal A, Triadafilopoulos G (2010) Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based study. Dig Dis Sci 55:1689–1695PubMedCrossRef

Bjarnason I, Hayllar J, Macpherson AJ, Russell AS (1993) Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 104:1832–1847PubMed

Bjarnason I, Scarpignato C, Takeuchi J, Rainsford KD (2007) Determinants of the short-term gastric damage caused by NSAIDs in man. Aliment Pharmacol Ther 26:95–106PubMedCrossRef

Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis VIGOR Study Group. N Engl J Med 343:1520–1528PubMedCrossRef

Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, Lee VW, Lai LH, Wong GL, Chow DK, To KF, Leung WK, Chiu PW, Lee YT, Lau JY, Chan HL, Ng EK, Sung JJ (2007) Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 369:1621–1626PubMedCrossRef

Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL (2010) Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 376:173–179PubMedCrossRef

Fenn GC (1994) Controversies in NSAID-induced gastroduodenal damage-do they matter? Aliment Pharmacol Ther 8:15–26PubMedCrossRef

Hayllar J, Macpherson A, Bjarnason I (1992) Gastroprotection and nonsteroidal anti-inflammatory drugs. Drug Safe 7:86–105CrossRef

Henry D, Dobson A, Turner C (1993) Variability in the risk of major gastrointestinal complications from nonsteroidal anti-inflammatory drugs. Gastroenterology 105:1078–1088PubMed

Henry D, Lim LL-Y, Rodrigues LAG, Gutthann PS, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 312:1563–1566

Jacob M, Simpson R, Bjarnason I (1998) Nonsteroidal anti-inflammatory drugs, cyclooxygenase selectivity and gastrointestinal toxicity. Ital J Gastroenterol Hepatol 30:12–18PubMed

Kaufman DW, Kelly JP, Sheehan JE, Laszlo A, Wiholm BE, Alfredsson L, Koft RS, Shapiro S (1993) Nonsteroidal antiinflammatory drug use in relation to major gastrointestinal bleeding. Clin Pharmacol Ther 53:485–494PubMedCrossRef

Ladwa M, Takeuchi K, Bjarnason I (2006) NSAIDs request parity with Helicobacter pylori. Scand J Gastroenterol 41:373–375PubMedCrossRef

Langman MJS (1989) Epidemiological evidence on the association between peptic ulceration and antiinflammatory drugs. Gastroenterology 96:640–646PubMed

MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG (1997) Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. Br Med J 315:1333–1337

Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I (2005) A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 128:1172–1178PubMedCrossRef

Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA (2010) Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 62:1592–1601PubMedCrossRef

Moore A, Bjarnason I, Cryer B, Garcia-Rodriguez L, Goldkind L, Lanas A, Simon L (2009) Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm. Clin Gastroenterol Hepatol. 7:1156–1163PubMedCrossRef

Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83:473–482PubMedCrossRef

Scarpignato C, Bjarnason I, Bretagne J-F, de Pouvourville G, Garcia Rodriguez LA, Goldstein JL, Muller P, Simon B (1999) Towards a GI safer antiinflammatory therapy. Gastroenterol Int 12:180–215

Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 364:665–674PubMedCrossRef

Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, Palizban A, Pombo J, Watts J, Morham SG, Bjarnason I (2002) COX-1 and 2, intestinal integrity and pathogenesis of NSAID-enteropathy in mice. Gastroenterology 122:1913–1923PubMedCrossRef

Silverstein FE, Graham GY, Senior JR, Davies HW, Struthers BJ, Bittman RM, Geis SG (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Int Med 123:241–249PubMed

Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Bur AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Study. JAMA 284:1247–1255PubMedCrossRef

Somasundaram S, Hayllar J, Rafi S, Wrigglesworth J, Macpherson A, Bjarnason I (1995) The biochemical basis of NSAID-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 30:289–299PubMedCrossRef

Tibble J, Sigthorsson G, Foster R, Scott D, Roseth A, Bjarnason I (1999) Faecal calprotectin: a simple method for the diagnosis of NSAID-induced enteropathy. Gut 45:362–366PubMedCrossRef

Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706–714PubMedCrossRef

Title: Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents
Authors: Guy Sisson
Ingvar Bjarnason
Publication date: 01-08-2011
Publisher: SP Birkhäuser Verlag Basel
Published in: Inflammopharmacology / Issue 4/2011
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-011-0085-5

At a glance: The STEP trials

Springer Medicine

Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2011

Paradigms in multiple sclerosis: time for a change, time for a unifying concept

Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents

A toxicological investigation of a celery seed extract having anti-inflammatory activity

Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction

Role of ghrelin-induced cSrc activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori

Anti-nociceptive effects of Carpolobia lutea G. Don (Polygalaceae) leaf fractions in animal models